-
Trump slams NBA's LeBron James for national anthem actions
-
New York votes to ban Central Park horse carriages after decades of debate
-
Australia sanctions North Koreans over 'fraudulent' IT work, cybercrime
-
Australia face selection headaches after 'shambolic' South Africa defeat
-
UK singer-songwriter Raye wins Mercury Prize for second album
-
Around 150,000 rally in Belgrade as Serbia heads to pivotal poll
-
Antonelli needs ‘perfect weekend’ to realise title dream
-
Hamilton sets sights on racing in African grand prix
-
Reclaiming the walls in a former Salvadoran gang hotspot
-
Bournemouth hammer 10-man Milan, Juventus denied at the death
-
Musk wants to merge SpaceX and Tesla: Here's what to know
-
Judge orders Trump to give deposition in BBC lawsuit by Dec 11
-
Musk's wants to merge SpaceX and Tesla: Here's what to know
-
'Fake' pollsters hit US midterms
-
Hashimoto sweeps to gymnastics world all-around title
-
Global markets retreat as tech mood sours, oil prices jump
-
Super Bowl MVP Walker returns to Seattle with unbeaten Chiefs
-
Juventus denied at the death, Sunderland make point in Poland in Europa League
-
Red Bull advisor Marko slams Horner memoir as 'collection of untruths'
-
Tens of thousands rally as Serbia heads to pivotal poll
-
France reports first human Shamonda virus case, says no health risk
-
Monet's 'Iris' fetches 50 mn euros at Paris auction
-
Rekindled Gucci desirability fails to light flame under Kering sales
-
L'Oreal sees double-digit sales growth
-
Thousands rally as Serbia heads to pivotal poll
-
Sri Lanka stun England with huge chase after Brook's 202
-
Marathon star Aga banned six years for doping and misleading investigation
-
Guatemala sentences former police officers in gay couple's killings
-
USA to host women's football Club World Cup in 2028 - FIFA
-
Nelson's erotic dream letter features in London auction
-
Finland grants licence for world's first nuclear waste repository
-
Canada opens free trade talks with Turkey
-
'Old-fashioned' South Africa thump Australia to level Test series
-
Swiss, Austrian women freed after Niger kidnap ordeal
-
No more taking out the trash at your Airbnb
-
Austrian-born French resistance fighter dies aged 105: regional official
-
Swiss supreme court upholds Guatemala ex-police chief sentence
-
Paris shop-owners and residents prepare for fresh protests
-
UN climate disaster fund moves to provide $20 mn aid for Nepal
-
French, Japanese authors try to write novel on one-day train ride
-
Africa faces 'complex' Ebola outbreak after spread to Nigeria: WHO
-
Pentagon, Lockheed announce agreement for 850 F-35 jets over 10 years
-
American detained in Russia arrives in US: lawyer
-
Brook scores fastest double century in ODI history in rampant England's 429-4
-
Pentagon, Lockheed announce deal for 850 F-35 jets over 10 years
-
Top-ranked Rybakina into Ningbo quarter-finals on return from injury
-
French authorities seek to ban or curb fresh protests
-
Samson superb as India mark record T20 chase in win over New Zealand
-
Nearly all coral reefs risk collapse in 50 years: IUCN
-
Nvidia boss criticises 'cheap' AI doomsday warnings
Medical Care Technologies Inc. (OTCID:MDCE) Positions StrainScan Pro Against the $4.8-$5 Trillion Global Agriculture Market
Field-Grade AI Vision for Crop Disease, Ripeness, Pest Damage and Yield Anomalies as the Company Advances Toward First Enterprise Clients
MESA, AZ / ACCESS Newswire / October 1, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today detailed StrainScan Pro's agricultural configuration - a field-grade visual intelligence layer aimed at one of the world's largest production markets, with global agricultural output frequently estimated near $4.8 trillion to $5 trillion.

The platform is live at https://strainscanpro.com. Agriculture vertical: https://strainscanpro.com/industries/agriculture.
StrainScan Pro is proprietary AI vision software designed for on-device and API-first deployment, including iPad Air. In agriculture, the engine is configured to inspect living crop rather than a finished plate or a warehouse case. Capture can be handheld, fixed-camera or drone imagery. Analysis is designed to flag visible indicators of disease, ripeness stage, pest damage, nutrient-stress appearance and yield irregularity at the plant, block or field level.
The intended field workflow is:
- Capture - image the crop at scale
- Analyze - run category-specific visual models against the selected crop
- Trend - compare current appearance against prior captures of the same block
- Alert - route exceptions when visual markers cross an operator-defined threshold
This is a continuation of MDCE's agricultural demonstration path, including produce-specific modules for leafy greens, berries, tomatoes and tree fruit. The Company is now presenting that field configuration as it looks toward first enterprise clients.
"Agriculture is where product still has a growing season attached to it," said Marshall Perkins, CEO of Medical Care Technologies. "A blight mark, a ripeness miss, or a pest hit is cheaper to see in the row than after the truck leaves. That is the job StrainScan Pro is being shown to do in this vertical."
This announcement describes a vertical configuration and demonstration activity. It does not constitute a signed customer contract or revenue forecast. StrainScan Pro is an enterprise visual analysis platform, not a medical device.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://www.medicalcaretechnologies.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: [email protected] | [email protected]
Websites: https://www.medicalcaretechnologies.com | https://strainscanpro.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
G.Stevens--AMWN